Related by context. All words. (Click for frequent words.) 65 ± SD 65 P = .# 65 p = #.# [002] 64 Â ± 63 n = 62 ≥ 61 p = 60 p = #.# [004] 60 % Confidence Interval 60 interquartile range 60 -#.# ± [001] 60 % CI #.#-#.# [003] 59 CI -#.# 59 PaO 2 59 p = .# [002] 59 sd = 59 MBq 59 confidence interval CI 59 pg mL 59 CI = 59 cm H2O 58 postoperatively 58 mmol L 58 μmol L 57 % CI #.#-#.# [006] 57 ng mL 57 + -1 57 QRS duration 57 -#.# ± [002] 57 QTcF 57 χ 56 = #.#-#.# 56 mL kg 56 μV 56 μH 56 LVEF 56 -#.# mg dL [002] 56 nmol liter 56 ° sec 56 ml min 56 μg mL 56 kΩ 55 confidence intervals CIs 55 mL/min/#.# m 2 55 p ≤ 55 P ≤ 55 pg ml 55 mL 55 % CI #.#-#.# [001] 55 min -1 55 mL sec 55 CI #.#-#.# [001] 55 kg -1 55 % CI #.#-#.# [002] 55 cm -2 55 mmol l 55 #.#-#.# [011] 55 microg 55 r = 55 ng dL 55 pmol L 55 MADRS score 55 left ventricular LV 55 g dL 55 % CI #.#-#.# [007] 55 mol L 54 μg d 54 highest tertile 54 creatinine ratio 54 detrusor 54 ± #.#dB 54 r2 = 54 stent binary restenosis 54 serum magnesium 54 nmol 54 p = NS 54 systolic diastolic 54 ‰ ¥ 54 WOMAC pain 54 lowest tertile 54 mm Hg 54 mg d 54 mU liter 54 kPa 54 confidence interval #.#-#.# 54 mm3 54 ug kg 54 ° ± 54 AUA Symptom Score 54 International Prostate Symptom 54 mIU ml 54 lumbar spine BMD 53 postop 53 posttreatment 53 pmol liter 53 μg L 53 fraction LVEF 53 mCi 53 mU L 53 mg kg 53 ± #ppm [001] 53 ≤ 53 mean baseline HbA1c 53 AUC0 53 nH 53 mmHg 53 leukocyte count 53 g dl 53 ng ml 53 ± #ppm [002] 53 #mV [001] 53 kg m² 53 dB insertion loss 53 fA 53 Cmax 53 IPSS 53 -#.# log# 53 uM 53 + #.#mm 53 mH 53 μg ml 53 % CI #.#-#.# [005] 53 √ Hz 53 #.#Hz 53 ml kg 53 logMAR 53 typ. 53 hemoglobin Hb 53 g cm 53 mm Hg diastolic 53 μg liter 53 median PFS 52 = -#.# 52 μg 52 placebo p 52 ^ sup 52 mM 52 4mg/kg 52 pulmonary arterial 52 nmol L 52 HbA 1c 52 hours postdose 52 crossclamp 52 mrad 52 Vrms 52 Î ¼ 52 msec 52 placebo p = 52 ± SEM 52 ± #.#mm [001] 52 per deciliter mg 52 lymph node metastasis 52 log# copies mL 52 mIU L 52 mm ² 52 #.#mmol L [002] 52 alanine aminotransferase 52 â ‰ ¥ 52 nonobese 52 nondiabetic patients 52 arterial oxygen saturation 52 reintervention 52 #Gy 52 mmHg p = 52 postintervention 52 % CI #.#-#.# [004] 52 ejection fractions 52 mΩ 52 preoperatively 52 pulmonary capillary wedge 52 mmol 52 pulsatility index 52 mg/# hours 52 endometrial thickness 52 mV 52 plasma leptin 52 euthyroid 52 MACCE 52 IQR 52 cGy 52 HOMA IR 52 cm2 51 AUCs 51 urine albumin 51 -#.# p = 51 normothermic 51 mmHg systolic 51 -#.# mg dL [001] 51 ng dl 51 -#.# mmol L 51 log# 51 preoperative 51 ug mL 51 mitral annular 51 mg dL 51 pF 51 interquartile range IQR 51 Supplementary Table 51 erythrocyte sedimentation rate 51 μm 51 mL min 51 conduction velocity 51 tertile 51 kcal d 51 PSA nadir 51 fractional shortening 51 #mmHg [001] 51 lispro 51 ug ml 51 Pearson correlation coefficient 51 mm Hg systolic 51 left ventricular systolic 51 baseline Hb 51 intact parathyroid hormone 51 serum ALT 51 ATV RTV 51 #Ω [002] 51 receiving ISENTRESS 51 mm 51 Left Ventricular Ejection Fraction 51 lopinavir r arm 51 failure MTTF 51 cm -3 51 nM 51 milliohm 51 mmHg diastolic 51 LV ejection fraction 51 cm sec 51 Diastolic 51 curve AUC 50 posttransplant 50 preoperative PSA 50 Hazard Ratio HR 50 +# deg [002] 50 aspartate aminotransferase 50 1ppm 50 Median survival 50 inspiratory 50 β = 50 HbA1C levels 50 arteriolar 50 PCWP 50 mcg mL 50 uL 50 mEq 50 ω 50 x ULN 50 mg kg bw 50 ventricular myocardium 50 #.#dB [003] 50 total harmonic distortion 50 mL/min/#.# m2 50 mmol kg 50 -# dB [001] 50 BPH Symptom Score 50 2dB 50 1kHz 50 intraclass correlation coefficient 50 CK MB 50 #.#V #.#V [001] 50 #mV [002] 50 #.#mm [002] 50 serum IGF 50 systolic function 50 microvolts 50 LAB GHRH 50 = .# 50 cm proximal 50 μL 50 postoperative 50 TAXUS p value 50 integral nonlinearity INL 50 ^ sup -1 50 psia 50 serum phosphorus 50 estimated glomerular filtration 50 mbar 50 nmol l 50 mg kg ip 50 Hb A1C 50 Hazard Ratio = 50 μF 50 TIMP 50 p = .# [001] 50 4mA 50 biochemical recurrence 50 torr 50 Ù 50 regression coefficient 50 mg kg dose 50 Hemoglobin A1c HbA1c 50 CI #.#-#.# [002] 50 Score IPSS 50 mild renal impairment 50 mol 50 #.#/#.# mm Hg [001] 50 Serum creatinine 50 BMI ≥ 50 nondiabetic 50 microampere 50 Operative mortality 50 % CI #.#-#.# [008] 50 mg ustekinumab 50 abdominal circumference 50 statistical significance p 50 mcg kg 50 serum potassium 49 #.#-#.# [005] 49 #mg/dL [002] 49 NNT = 49 statistically significant p = 49 μg dL 49 ropivacaine 49 mu m 49 z = 49 Visual Analogue Scale VAS 49 preintervention 49 intima media thickness 49 HBeAg seroconversion 49 creatine phosphokinase 49 creatinine clearance 49 IU ml 49 μg g 49 -#.# log# copies mL 49 inotropic 49 AOR = 49 σ 49 THD + N 49 MMSE score 49 mEq L 49 FEV ^ sub 49 FRAP 49 ° preoperatively 49 Fig. 2A 49 #.#V [003] 49 Secondary endpoints 49 creatine kinase MB 49 Median PFS 49 diameter stenosis 49 output voltage 49 Baseline characteristics 49 max. 49 mcg QD 49 kBq 49 Quiescent current 49 splanchnic 49 tertiles 49 hip BMD 49 Secondary endpoints included 49 serum HBV DNA 49 Postoperative 49 SUVmax 49 output capacitance 49 rms 49 Hb A1c 49 cells mcL 49 femoral neck BMD 49 mU 49 ìg 49 Total Harmonic Distortion 49 μg kg 49 EDSS score 49 multivariable analysis 49 progression TTP 49 plasma uric acid 49 #mm x #.#mm [001] 49 mean ± SEM 49 aged ≥ 49 postdose 49 picometers 49 -# dBm [001] 49 x #.#mm [001] 49 systolic 49 SpO 2 49 μmol 49 kg/m2 49 thyroglobulin 49 univariate analysis 49 mg QD 49 Hb 49 biopsy Gleason 49 CI -#.# -#.# 49 uV 49 lactate dehydrogenase 49 dehydroepiandrosterone sulfate 49 femoral neck 49 typ 49 mV V 49 #.#/#.# mmHg [001] 49 mean baseline A1C 49 ± ± 49 intraobserver 49 Kaplan Meier 49 hemodynamic parameters 49 + #.#dB 49 ß = 49 atheroma volume 49 Ncm 49 normal ULN 49 μW 49 mg qd 49 dBFS 49 #ug [002] 49 vasopressor 49 SBP DBP 49 ADAS cog 48 #.#mg/dL 48 RVOT 48 +6 dB 48 diopters 48 μl 48 mg Lucentis 48 Montgomery Åsberg Depression 48 #mm Hg 48 ppm ° C 48 #.#μF 48 differential nonlinearity DNL 48 α 48 mg TID 48 partial thromboplastin 48 ± #.#mm [002] 48 R RW CD-R/RW 48 systolic dysfunction 48 mGy 48 mcg BID 48 #mg/kg [002] 48 serum concentrations 48 #.#ng/ml 48 #.#,#.# [002] 48 #.#Ω 48 m ^ sup 48 Gy 48 linewidth 48 Input voltage 48 statistically significant p 48 ANOVA 48 Å -1 48 creatine kinase 48 #mmHg [002] 48 Left ventricular 48 fasting triglycerides 48 mg tid 48 ALT elevation 48 sinus rhythm 48 #mV V 48 reactive hyperemia 48 normoxic 48 infarct size 48 CIBIC plus 48 Key secondary endpoints 48 oxycodone CR 48 varus valgus 48 apnea hypopnea index 48 TURBT 48 #.#V [002] 48 baseline HbA1c 48 #.#mmol L [001] 48 spine BMD 48 #.#mV 48 IU mL 48 interval #.#-#.# 48 θ 48 ventricular mass 48 cm ² 48 fractional anisotropy 48 Breslow thickness 48 biochemical relapse 48 ≈ 48 6MWD 48 intraoperative 48 maximal 48 pT3 48 degC 48 isoprostane 48 Pain Intensity 48 mg kg Hematide 48 mmol L. 48 nonsignificant difference 48 diastolic hypertension 48 +# ° C [002] 48 intraclass correlation coefficients 48 #μF [001] 48 hypophosphatemia 48 #μg [001] 48 achieved ACR# 48 glycosylated hemoglobin HbA1c 48 lymphocytosis 48 NIHSS score 48 mmol liter 48 Postoperatively 48 corrected QT interval 48 ohm cm 48 logistic regression analysis 48 x#.# [002] 48 #.#pF 48 postoperative complication 48 DAS# CRP 48 mcg 48 Figure 1A 48 alanine aminotransferase ALT 48 multiple logistic regression 48 candelas per 48 nC 48 IIIa inhibitors 48 ipsilateral 48 aortic crossclamp 48 ejection fraction EF 48 μM 48 serum TSH 48 TIMP 1 48 nondiabetics 48 HbA 1c levels 48 Main Outcome Measures 48 ultrasonographic 48 mso footer margin 48 -# ° [002] 48 ν 48 alanine transaminase 48 -#.# mm Hg 48 thermal EMF 48 diastolic BP 48 Psoriasis Area 48 megohms 48 aspartate aminotransferase AST 48 EBRT 48 odds ratios ORs 48 Index CDAI 48 mK 48 nonfatal MI 48 ppm ° C. 48 0V 48 NYHA functional class 48 #μs [002] 48 EQ 5D 48 Si#DB 48 comparator arm 47 nmol L. 47 Si#DP 47 Preoperatively 47 clinically meaningful improvement 47 GORE TAG Device 47 statistically significant 47 specific antigen PSA 47 autoregulation 47 #.#in [004] 47 pulsatile flow 47 systolic BP 47 DAS# [002] 47 #OHD 47 kappa = 47 aOR 47 pulmonary artery pressure 47 Fasting plasma glucose 47 lumen diameter 47 CABG p = 47 #.#mohm 47 mg 47 Systolic 47 #V ac 47 hypogonadal 47 input capacitance 47 COHb 47 mg Androxal 47 cTnI 47 fluence 47 1μm 47 microvolt 47 λ 47 mcg ml 47 luminal 47 arcsec 47 tPSA 47 afterload 47 mg dl 47 nodular partial response 47 #.#mmHg 47 fasting insulin 47 MetS 47 -#.# mmHg 47 g mL 47 ¡ À 47 #mg BID [001] 47 #.#μm [001] 47 mA 47 glomerular filtration rate 47 nonsignificant 47 dyspnea 47 rectal temperature 47 mOhm 47 V ac 47 antral 47 mRNA expression 47 mercury mm Hg 47 mm2 47 8kV 47 = [031] 47 Ñ Ð 47 DHCA 47 concentration Cmax 47 tirofiban 47 SCr 47 mA output 47 mCi m 2 47 Apidra ® 47 serum testosterone 47 Fig. 1D 47 standard deviation 47 inductance values 47 eGFR 47 GOVERNMENT MEETINGS 47 MΩ 47 mg p = 47 lumbar spine bone 47 ZXLD# 47 LDL triglycerides 47 SpO2 47 subscale scores 47 corneal curvature 47 β 47 df = 47 Unified Parkinson Disease 47 ps rms 47 mm diameters 47 diaphysis 47 dBm output 47 Median progression 47 pmol 47 binary restenosis 47 peak VO2 47 articular 47 plasma glucose 47 echocardiographic 47 Ð Ð 47 ρ 47 ischemia driven 47 fig. S2 47 ED# [002] 47 temperature coefficient 47 μSv 47 MIC# [001] 47 HAQ DI 47 ACLR 47 primary patency 47 Kaplan Meier analysis 47 cm 47 μA 47 Khz 47 kDa 47 pg g 47 leukopenia 47 K + ATPase 47 ventricular function 47 CR nPR 47 ULN 47 waist girth 47 hemodynamically significant 47 #.#-#.# p = 47 cerebral perfusion 47 parenchymal 47 OGTT 47 μsec 47 urinary albumin excretion 47 univariate analyzes 47 Fig. 1B 47 ¾ î 47 fasting plasma 47 Intraocular pressure 47 RYGB 47 induration 47 serum estradiol 47 5mA 47 hemoglobin A1c HbA1c 47 histologic 47 1dB 47 urinary albumin 47 seminal vesicle invasion 47 Doppler sonography 47 mCi kg 47 HbA1C 47 dc converter 47 rCBF 47 +#.# dBm [001] 47 1MHz 47 hsCRP levels 47 íà 47 ohms 47 glulisine 47 REYATAZ r arm 47 contralateral 47 umol L 47 resection 47 cerebral oxygenation 46 mAs 46 μg dl 46 bivalirudin monotherapy 46 atazanavir ritonavir 46 microfarads 46 anteroposterior 46 pCR 46 baseline serum creatinine 46 mmHg p 46 septal 46 pooled comparator 46 serum albumin 46 PSIG 46 kcal mol 46 Transesophageal 46 ventricular ejection fraction 46 LANTUS R 46 subscore 46 hypogonadal men 46 HIV RNA 46 troponin T 46 vastus lateralis 46 serum phosphate levels 46 UPDRS 46 ppm deg 46 interrater reliability 46 total cholesterol triglycerides 46 PASI scores 46 dBc 46 severe neutropenia 46 tibiofemoral 46 normotensive 46 ¸ ° 46 advanced adenoma 46 fasting glucose 46 #ppm ° C 46 #.#/#.# mm Hg [003] 46 PSQI 46 left ventricular diastolic 46 CrCl 46 Alzheimer Disease Assessment 46 ³ ³ 46 dyssynchrony 46 SGRQ 46 ROC curve 46 albumin excretion rate 46 #.#V [001] 46 reoperation 46 SGPT 46 echogenicity 46 ÀÌ 46 BMI waist circumference 46 FDG uptake 46 intraventricular 46 telopeptide 46 FEV1 46 ° C ± 46 PREZISTA ritonavir 46 NIHSS 46 T2 weighted 46 Deg C 46 mcL 46 · Î 46 locoregional recurrence 46 prescaler 46 Eq. 46 Intraoperative 46 #mm# [001] 46 milliliter ng ml 46 Vpp 46 extracapsular extension 46 oxygen desaturation 46 micrograms ml 46 Ca2 + 46 rho = 46 distensibility 46 manometry 46 μs 46 genu 46 neointimal 46 fructosamine 46 deoxy 46 RMS jitter 46 nontreated 46 Scale cognitive subscale 46 #Ω [001] 46 #mg QD [002] 46 tapentadol ER 46 peritumoral 46 retinal thickness 46 neutrophil count 46 undetectable HBV DNA 46 homozygotes 46 QTc 46 serum prostate 46 Cream USP 1 46 multivariable adjusted 46 logistic regression model 46 g l 46 mg/m2/day 46 mIU mL 46 serum cortisol 46 ratiometric 46 ms -1 46 residual stenosis 46 3mg 46 TLUS 46 vertebral 46 ¿ ¡ 46 #mg/day [002] 46 diastolic velocity 46 Score DAS# 46 hemoglobin concentration 46 Hazard Ratio 46 ipsilateral stroke 46 GH deficiency 46 Lumbar spine 46 diastolic pressures 46 #.#uF 46 +# degreesC 46 immunoreactive 46 baseline CD4 46 #ng/ml 46 HbA1c levels 46 graft patency 46 diastolic dysfunction 46 baseline neutrophil counts 46 iliac crest bone 46 epididymal 46 tumor progression TTP 46 #.#ml [003] 46 #VAC [002] 46 PANSS total 46 alkaline phosphatase 46 hypothermic circulatory arrest 46 FACIT Fatigue 46 #mg/dL [001] 46 decibel dB 46 Qmax 46 Cronbach alpha 46 bypass graft CABG surgery 46 achieved statistical significance 46 serum urate levels 46 tipranavir r 46 statistically significant reduction 46 Fig. 1b 46 Fig. 4c 46 Fig. 3b 46 mg + GLY 46 À º 46 timepoints 46 endothelium dependent 46 hemoglobin concentrations 46 foveal thickness 46 serum ferritin 46 oxyhemoglobin 46 +# º C [001] 46 Supplementary Fig 46 retropubic 46 radiotherapy RT 46 systolic blood pressures 46 mg/m2 dose 46 infarct 46 vertebrobasilar 46 opacification 46 aggrecan 46 milliampere 46 adjunctive placebo 46 GERD symptom 46 aminotransferases 46 interobserver 46 mV g 46 osmolality 46 gr t Au 46 input impedance 46 nonobese patients 46 Hgb 46 hemodynamics 46 RC oscillator 46 #dBc 46 6V 46 picoseconds ps 46 VGS = 46 Ejection Fraction 46 systolic diastolic blood 46 #.#mm x [001] 46 1dB gain 46 dc converters 46 milliliters mL 46 LPV r 46 mg m² 46 kidney allograft 46 specific alkaline phosphatase 46 plasminogen activator inhibitor 46 Secondary endpoints include 46 appendiceal 46 Secondary efficacy endpoints 46 plus methotrexate 46 ± 3dB 46 maximal aerobic capacity 46 psec 46 serum PTH 46 ng g 46 Apgar scores 46 dI dV 46 #.#mm x #.#mm [001] 46 #pF [001] 46 AST ALT 46 FOLFIRI alone 46 XIENCE V vs. 46 NIH CPSI 46 hypothalamic pituitary 46 D dimer 46 temperature coefficients 46 -# mV [001] 46 NYHA class 46 XIENCE V PROMUS Stent 46 locomotor activity 46 lx 46 biventricular repair 46 dB 46 -5 -6 46 mrem 46 corneal thickness 46 wedge resection 46 esophagogastroduodenoscopy 46 THENCE SOUTH 46 radial artery grafts 46 lactate dehydrogenase LDH 46 RBC transfusion 46 estimated GFR 46 mercury mmHg 46 Fasting blood glucose 46 heterozygotes 46 serum creatinine 46 coronary stenosis 46 4dB 46 -# mV [002] 46 Ω 46 #Hz #kHz 46 gran parte 46 log# IU mL 46 #,#-#,# [008] 46 triiodothyronine 45 ventricular dilatation 45 mg/m2 45 Fig. 2C 45 surgically resected 45 P0 45 BMS p = 45 ha -1 45 achieved PASI 45 noncardiac 45 ± #V [002] 45 IELT 45 coefficients 45 pegylated interferon alfa 2b 45 thrombus formation 45 Figs. 45 6dB 45 WOMAC scores 45 Fig. 1a 45 input voltage 45 systemic embolism 45 periprocedural 45 LS BMD 45 nanograms milliliter 45 #.#m #.#m #.#m [003] 45 morphometric vertebral fractures 45 sUA levels 45 invasive angiography 45 graft occlusion 45 ACR# response 45 Solid Tumors RECIST 45 8mg/kg 45 sodium excretion 45 carotid intima media 45 bioavailable testosterone 45 neurologic progression 45 plasma creatinine 45 ° ú 45 hMG 45 hypoperfusion 45 5VDC 45 thickness IMT 45 oral glucose tolerance 45 CORE OM 45 ⁰ C 45 magnitude EVM 45 κ 45 dimensional echocardiography 45 mW cm 2 45 +# deg C [002] 45 phonophobia 45 coefficient 45 cd m 45 1kV 45 serum uric acid 45 femoral shaft fracture 45 umbilical vein 45 echocardiographic parameters 45 NPH insulin 45 Myoglobin 45 stimulated insulin secretion 45 ^ F FDG 45 AUA BPH Symptom Score 45 plasma lipids